2019
DOI: 10.3389/fphys.2019.00675
|View full text |Cite
|
Sign up to set email alerts
|

Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?

Abstract: Optogenetic methods enable selective de- and hyperpolarization of cardiomyocytes expressing light-sensitive proteins within the myocardium. By using light, this technology provides very high spatial and temporal precision, which is in clear contrast to electrical stimulation. In addition, cardiomyocyte-specific expression would allow pain-free stimulation. In light of these intrinsic technical advantages, optogenetic methods provide an intriguing opportunity to understand and improve current strategies to term… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(26 citation statements)
references
References 90 publications
0
26
0
Order By: Relevance
“…Compared with conventional electrical methods, cardiac optogenetics presents many remarkable advantages in optical manipulation, including precision and flexibility as well as being contactless and painless. These advantages highlight its potential in various translational applications in clinical devices for managing heart rhythm and function [14,26,27]. In most experiments, ChR2 and its mutant (ChR2-H134R) have been widely used as optogenetic actuators with a corresponding action spectrum at ∼470 nm but displayed poor tissue penetration.…”
Section: Discussionmentioning
confidence: 99%
“…Compared with conventional electrical methods, cardiac optogenetics presents many remarkable advantages in optical manipulation, including precision and flexibility as well as being contactless and painless. These advantages highlight its potential in various translational applications in clinical devices for managing heart rhythm and function [14,26,27]. In most experiments, ChR2 and its mutant (ChR2-H134R) have been widely used as optogenetic actuators with a corresponding action spectrum at ∼470 nm but displayed poor tissue penetration.…”
Section: Discussionmentioning
confidence: 99%
“…With optical actuation, light modulates cellular behaviour using techniques such as optogenetics and optically caged compounds [30,31,84,[90][91][92][93][94]. Bruegmann et al [93,94] have illustrated optogenetic actuation of in vitro and in vivo mouse cardiac tissues including defibrillation of ventricular tachycardia.…”
Section: Optical Techniques In Tissue Culturementioning
confidence: 99%
“…With optical actuation, light modulates cellular behaviour using techniques such as optogenetics and optically caged compounds [ 30 , 31 , 84 , 90 94 ]. Bruegmann et al .…”
Section: In Vitro Approaches To Examine Neuro-cardiac Interamentioning
confidence: 99%
“…Functionally, ChRs are divided into cation and anion channelrhodopsins (CCRs and ACRs, respectively) (8). Both ChR classes serve for photocontrol of excitable cells, such as neurons and cardiomyocytes, via a biotechnique known as optogenetics (9, 10). However, structural determinants for cation and anion selectivity in ChRs remain poorly understood.…”
Section: Introductionmentioning
confidence: 99%